BROOKE HENSCHEL: Open Payments
NPI 1245809714 · NEENAH, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,327 in 35 payments from 22 companies in 2025. Trend: 2023 $472 · 2024 $792 · 2025 $1,327
Food & beverage: $1,216Education: $111
| Company | Payments | Amount |
|---|---|---|
| EMD Serono, Inc. | 2 | $241 |
| UCB, Inc. | 2 | $158 |
| Teva Pharmaceuticals USA, Inc. | 2 | $138 |
| Alexion Pharmaceuticals, Inc. | 2 | $134 |
| Merz Pharmaceuticals, LLC | 2 | $65 |
| Biogen, Inc. | 1 | $59 |
| CATALYST PHARMACEUTICALS, INC. | 2 | $59 |
| Tanabe Pharma America, Inc. | 3 | $57 |
| Otsuka America Pharmaceutical, Inc. | 2 | $56 |
| Lilly USA, LLC | 3 | $52 |
Products named: Mavenclad, Briviact, ULTOMIRIS, FIRDAPSE, Radicava, REXULTI, INBRIJA, QULIPTA.
Industry payments across WI — which companies pay providers there.
